OWL(Biotechnology) Overview
- Founded
- 2004
- Status
- Private
- Employees
- 30
- Latest Deal Type
- 2ndary - Private
- Investors
- 2
OWL(Biotechnology) General Information
Description
Operator of a biotechnology company intended to use metabolomics to develop products for the early diagnosis of diseases and research and development services. The company focuses on the field of metabolomics and develops and produces blood-test-based non-invasive diagnostic systems, enabling medical and pharmaceutical companies to diagnose diseases of the liver and non-alcoholic steatohepatitis.
Contact Information
Website
www.owlmetabolomics.com
Formerly Known As
One Way Liver Genomics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Discovery Tools (Healthcare)
Primary Office
- Bizkaia Technology Park
- Building 502 - Floor 0
- 48160 Derio
- Spain
+34 944 00 00 00
OWL(Biotechnology) Timeline
OWL(Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Secondary Transaction - Private | 01-Jan-2021 | 000.00 | Completed | Generating Revenue | ||
| 7. Equity Crowdfunding | 02-Jul-2020 | 00000 | 000.00 | Cancelled | Generating Revenue | |
| 6. Later Stage VC | 19-Dec-2019 | 00.000 | 000.00 | 000.00 | Completed | Generating Revenue |
| 5. Later Stage VC | 13-Mar-2015 | 00000 | 00.000 | 000.00 | Completed | Generating Revenue |
| 4. Later Stage VC | 24-Jan-2011 | 00.000 | 00.000 | 000.00 | Completed | Generating Revenue |
| 3. Later Stage VC | 06-Jul-2010 | 00.000 | 00.000 | 000.00 | Completed | Generating Revenue |
| 2. Early Stage VC | 04-Dec-2009 | $748K | $4.56M | Completed | Generating Revenue | |
| 1. Early Stage VC | 24-Nov-2008 | $3.81M | $3.81M | Completed | Generating Revenue |
OWL(Biotechnology) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 0,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | |
| Ordinary | 000 | 00.000000 | 00000.00 | 00000.00 | 00 | 00000.00 | 0.000 | |
| Ordinary | 2,000 | $1.107064 | $1107.06 | $1107.06 | 1x | $1107.06 | 10.26% | |
| Ordinary | 1,370 | $1.107064 | $808.08 | $808.08 | 1x | $808.08 | 7.02% |
OWL(Biotechnology) Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a biotechnology company intended to use metabolomics to develop products for the early diagnosis of diseases
Biotechnology
Derio, Spain
30
As of 2021
000.00
00000000000
000.00
0000 000
t amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliq
0000 000000000
Cincinnati, OH
00.000
000000&0
00.000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialOWL(Biotechnology) Competitors (1)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 0000 000 000000000 | Formerly VC-backed | Cincinnati, OH | 00.000 | 000000&0 | 00.000 |
OWL(Biotechnology) Patents
OWL(Biotechnology) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3482213-A1 | Diagnostic methods based on lipid profiles | Granted | 06-Jul-2016 | 000000000 | |
| EP-3482213-B1 | Diagnostic methods based on lipid profiles | Active | 06-Jul-2016 | 000000000 | |
| ES-2839514-T3 | Diagnostic methods based on lipid profiles | Active | 06-Jul-2016 | 000000000 | |
| EP-3267199-A1 | Diagnostic methods based on lipid profiles | Withdrawn | 06-Jul-2016 | 000000000 | 0 |
| US-20190219602-A1 | Diagnostic methods based on lipid profiles | Abandoned | 06-Jul-2016 | G01N33/92 |
OWL(Biotechnology) Executive Team (9)
OWL(Biotechnology) Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Ángel Santos | OWL(Biotechnology) | Chief Executive Officer, President, Executive Director & Chairman | 000 0000 |
OWL(Biotechnology) Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialOWL(Biotechnology) Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Kereon Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| CRB Inverbio | Venture Capital | Minority | 000 0000 | 000000 0 |
OWL(Biotechnology) Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 0000 | 10-Feb-2010 | 0000000000 | Biotechnology | 0000á0 0á | |
| Metabolic Renal Disease | 10-Feb-2010 | Merger/Acquisition | Other Healthcare Services |